RA
CHTP

Royce & Associates’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Royce & Associates’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-120,000
Closed -$532K – 1503
2013
Q4 		$532K Sell
120,000
-440,000
-79% -$1.49M ﹤0.01% 1231
2013
Q3 		$1.69M Sell
560,000
-70,000
-11% -$201K 0.01% 1102
2013
Q2 		$1.45M Buy
+630,000
New +$1.27M ﹤0.01% 1098

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates's CHTP Position: Q1 2014 in Review

Royce & Associates sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 120,000 shares — an estimated $532K sold.

Royce & Associates first reported a position in CHTP in Q2 2013 and held it in 3 quarters. The position peaked at $1.69M in Q3 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • Royce & Associates reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • Royce & Associates sold 120,000 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $532K.
  • Royce & Associates first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 3 quarters.
  • Royce & Associates's CHELSEA THERAPEUTICS INT'L LTD position peaked at $1.69M in Q3 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.